BioCentury | Jan 12, 2021
Finance

Jan. 11 Quick Takes: Megarounds for Valo, Visen; plus NuProbe, Sensei

...led the round with participation from OrbiMed Advisors, Sherpa Healthcare Partners, Cormorant, HBM Healthcare Investments, Pivotal bioVenture Partners...
BioCentury | Nov 19, 2020
Finance

Nov. 18 Quick Takes: Venture rounds for Elevation, Pharvaris as Kodiak follow-on brings in $560M; plus AbCellera takes out Trianni for $90M and more

...of 5.2 million shares at $108.Dermira alums land seed funding for start-up Evommune San Francisco firm Pivotal bioVenture Partners...
BioCentury | Jul 2, 2020
Emerging Company Profile

Bolt’s myeloid twist on ADCs charged up with $93.5M series C

...Capital, Samsara BioCapital and Pfizer Ventures, along with existing investors including Novo Holdings, Vivo Capital, Pivotal bioVenture Partners...
...partners: N/A Number of employees: 55 Funds raised: $170 million Investors: Novo Holdings, Vivo Capital, Pivotal bioVenture Partners...
BioCentury | Jun 26, 2020
Finance

Akouos’ first-day pop outshines peers among NASDAQ IPO trio

...of $552.2 million. Shareholders with stakes larger than 5% include 5AM Ventures, New Enterprise Associates, Pivotal bioVenture Partners...
BioCentury | Jun 6, 2020
Finance

Legend’s $424M NASDAQ offering pads 2020’s lead over prior years

...therapies for hearing loss, raised $105 million in a March series B round led by Pivotal bioVenture Partners...
BioCentury | Jun 4, 2020
Management Tracks

Giroir stepping down as COVID-19 testing czar; plus Gilead, Sanofi Ventures, Varian, Sirtex and Oxford BioMedica

...of Sanofi (Euronext:SAN; NASDAQ:SNY) in April as head of investments; he was a VP at Pivotal bioVenture Partners...
BioCentury | May 20, 2020
Finance

$145M raise positions Rallybio to bring first rare disease program into clinic

...acquire three rare disease programs, Rallybio has raised a $145 million series B led by Pivotal bioVenture Partners...
BioCentury | Apr 28, 2020
Finance

April 27 Quick Takes: Avalyn raises $35M for fibrosis therapies, plus Actym, LifeSprout, HebeCell, Compass, Immunomic

...in 2017. The round was led by Norwest Venture Partners with participation from new investor Pivotal bioVenture Partners...
BioCentury | Mar 26, 2020
Finance

SutroVax heading to clinic with potential competitor to Pfizer’s Prevnar 13

...all of the company’s existing institutional investors TPG Growth, Abingworth, Longitude Capital, Frazier Healthcare Partners, Pivotal bioVenture Partners...
BioCentury | Jan 11, 2020
Company News

Led by Blatt, Aligos reunites Alios team to develop functional cure for HBV

...include funds managed by Janus Henderson Investor, Boxer Capital of Tavistock Group, Cormorant Asset Management, Pivotal bioVenture Partners...
Items per page:
1 - 10 of 44
BioCentury | Jan 12, 2021
Finance

Jan. 11 Quick Takes: Megarounds for Valo, Visen; plus NuProbe, Sensei

...led the round with participation from OrbiMed Advisors, Sherpa Healthcare Partners, Cormorant, HBM Healthcare Investments, Pivotal bioVenture Partners...
BioCentury | Nov 19, 2020
Finance

Nov. 18 Quick Takes: Venture rounds for Elevation, Pharvaris as Kodiak follow-on brings in $560M; plus AbCellera takes out Trianni for $90M and more

...of 5.2 million shares at $108.Dermira alums land seed funding for start-up Evommune San Francisco firm Pivotal bioVenture Partners...
BioCentury | Jul 2, 2020
Emerging Company Profile

Bolt’s myeloid twist on ADCs charged up with $93.5M series C

...Capital, Samsara BioCapital and Pfizer Ventures, along with existing investors including Novo Holdings, Vivo Capital, Pivotal bioVenture Partners...
...partners: N/A Number of employees: 55 Funds raised: $170 million Investors: Novo Holdings, Vivo Capital, Pivotal bioVenture Partners...
BioCentury | Jun 26, 2020
Finance

Akouos’ first-day pop outshines peers among NASDAQ IPO trio

...of $552.2 million. Shareholders with stakes larger than 5% include 5AM Ventures, New Enterprise Associates, Pivotal bioVenture Partners...
BioCentury | Jun 6, 2020
Finance

Legend’s $424M NASDAQ offering pads 2020’s lead over prior years

...therapies for hearing loss, raised $105 million in a March series B round led by Pivotal bioVenture Partners...
BioCentury | Jun 4, 2020
Management Tracks

Giroir stepping down as COVID-19 testing czar; plus Gilead, Sanofi Ventures, Varian, Sirtex and Oxford BioMedica

...of Sanofi (Euronext:SAN; NASDAQ:SNY) in April as head of investments; he was a VP at Pivotal bioVenture Partners...
BioCentury | May 20, 2020
Finance

$145M raise positions Rallybio to bring first rare disease program into clinic

...acquire three rare disease programs, Rallybio has raised a $145 million series B led by Pivotal bioVenture Partners...
BioCentury | Apr 28, 2020
Finance

April 27 Quick Takes: Avalyn raises $35M for fibrosis therapies, plus Actym, LifeSprout, HebeCell, Compass, Immunomic

...in 2017. The round was led by Norwest Venture Partners with participation from new investor Pivotal bioVenture Partners...
BioCentury | Mar 26, 2020
Finance

SutroVax heading to clinic with potential competitor to Pfizer’s Prevnar 13

...all of the company’s existing institutional investors TPG Growth, Abingworth, Longitude Capital, Frazier Healthcare Partners, Pivotal bioVenture Partners...
BioCentury | Jan 11, 2020
Company News

Led by Blatt, Aligos reunites Alios team to develop functional cure for HBV

...include funds managed by Janus Henderson Investor, Boxer Capital of Tavistock Group, Cormorant Asset Management, Pivotal bioVenture Partners...
Items per page:
1 - 10 of 44